Account
Inquiry
The LHP-12 Nitric Oxide Analyzer is a precision medical device designed to assist healthcare professionals in asthma diagnosis and treatment management. This advanced analyzer measures fractional exhaled nitric oxide (FeNO), a key biomarker for airway inflammation.
With asthma prevalence increasing globally, accurate FeNO measurement has become essential in modern respiratory care. Clinical studies show that after FeNO measurement, clinicians modify treatment plans in 40% of cases, demonstrating the device's significant impact on patient outcomes.
The analyzer features an intuitive interface with guided test animations, ensuring excellent user experience for both medical staff and patients. Its lightweight, portable design (145×180×57mm) allows for easy movement within clinical settings.
Key clinical benefits include the ability to store large amounts of patient data for longitudinal management and the potential to reduce asthma exacerbations by 50% when used for regular patient monitoring. The device's rapid <60 second preheating time and ≈60s analysis speed enable efficient workflow in busy medical practices.
The LHP-12 meets international standards with CE certification and is particularly suitable for middle-aged and older patient populations. Its mainstream technology ensures reliable measurements across the 5-300ppb test range, with both 6-second and 10-second expiratory time options available.
This professional medical equipment represents an important tool for implementing global asthma care guidelines that recommend FeNO testing. By providing objective measurements of airway inflammation, it helps clinicians make more confident treatment decisions and optimize asthma management strategies.
The analyzer's compact dimensions and standard export packaging make it suitable for various clinical environments, from hospital respiratory departments to specialized asthma clinics. Its durable construction ensures long-term reliability in demanding healthcare settings.
